Skip to main content
OpenTrials
Completed

NCT Number: NCT00261937

Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bronchiolitis Bronchial Diseases Bronchitis Infections Lung Diseases Lung Diseases, Obstructive Respiratory Tract Diseases Respiratory Tract Infections

Age range

1 day–12 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Bnai Zion Medical Center and Naharia Galilli Medical Center

Haifa, 31048, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 0-12 months.
  • Infants who are otherwise healthy
  • Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
  • Parents signed a written informed consent.

Exclusion criteria

  • • Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.

Treatment and study plan

Inhaled Furosemide vs Placebo (Normal Saline)

Drug

Primary outcomes

  1. Clinical respiratory effects

Secondary outcomes

  1. 1. The duration of hospitalization

  2. 2. Time weaned off oxygen

  3. 3. Time to full enteral feeding

Sponsors and collaborators

Lead sponsor

Bnai Zion Medical Center

Other Gov

Registry information

Important dates

Study start
2005
Study completion
2006
First posted
Dec 6, 2005
Registry last updated
Feb 6, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.